BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance

  Maravai LifeSciences Holdings, Inc., a global provider of life science reagents and services to researchers and biotech innovators, reported financial results for the fourth quarter and the full year ended December 31, 2021, together with other business updates.

  February 23, 2022

   · 

  17 min read
• Business

  Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results

  Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, reported financial results for its fourth quarter and full year ended December 31, 2021.

  February 23, 2022

   · 

  9 min read
• Business

  Amedisys Reports Fourth Quarter and Year End 2021 Financial Results; Issues 2022 Guidance

  Amedisys, Inc. reported its financial results for the three-month period and year ended December 31, 2021.

  February 23, 2022

   · 

  27 min read
• Business

  Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

  Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the fourth quarter and full year ended December 31, 2021.

  February 23, 2022

   · 

  10 min read
• Lone Star Bio

  OsteoCentric Technologies introduces THEIR Mechanical Integration UnifiMI technology to the $7.6b spinal fusion market

  OsteoCentric Technologies, the pioneer of Mechanical Integration, announces the execution of a private label agreement with Altus Spine which will propel their subsidiary, OsteoCentric Spine, LLC, into the pedicle screw fixation space.

  February 23, 2022

   · 

  2 min read
• Therma Bright Receives Patent for a Device for Applying a Topical Treatment from U.S. Patent & Trademark Office (USPTO)

  This U.S. patent applies to both Therma Bright’s InterceptCS™ Cold Sore Prevention Device and TherOZap™ Insect Bite Relief Device.

  February 23, 2022

   · 

  4 min read
• PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

  PharmaDrug receives encouraging potency data for candidate DMT-analogue molecules designed to treat primary open angle glaucoma

  February 23, 2022

   · 

  13 min read
• Alkyl Amines Market Size to Reach USD 9,453.2 Million in 2028 | Reports And Data

  Increasing global population, coupled with rising demand for several products, in which alkyl amines are used as raw material, are factors driving market revenue growth.

  February 23, 2022

   · 

  7 min read
• Enzymes Market Size to Reach USD 17.84 Billion in 2028 | Industry Trend – Rising Demand for High-Quality Pharmaceutical, Food & Beverage and Personal Care Products

  Increasing health awareness among the population and growing demand for specialty and industrial enzymes in the pharmaceutical and food & beverage industries are among the key factors driving market revenue growth.

  February 23, 2022

   · 

  7 min read
• Business

  Spark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo; COO Ron Philip Named as Successor

  Spark Therapeutics, a member of the Roche Group and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, announced that Ron Philip, Spark’s chief operating officer, will succeed co-founder Jeffrey D. Marrazzo as chief executive officer.

  February 23, 2022

   · 

  4 min read